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MAINE DRUG-INDUCED MORTALITY, 2015 UPDATE

Patterns of Drug-induced Mortality in Maine,
2015 Update
by Marcella H. Sorg, Margaret Greenwald, and Jamie A. Wren
Drug addiction and drug-induced mortality have received a good deal of attention nationally and in Maine in recent
years. The authors review overall trends in the patterns of drug overdoses that have continued for nearly two decades,
including those involving opioid pharmaceuticals, and discuss the recent resurgence of the illicit drugs heroin and
non-pharmaceutical fentanyl.

S

ubstance abuse and legitimate drug use in Maine
exist along a complex series of continua. Use of
illegal drugs by socially marginal people is only one
extreme of a large, interrelated set of behavior patterns.
Those who die from drug overdose come from all walks
of life. They include people of all ages, although they
disproportionately affect young and middle age adults.
This marks the nineteenth year for which the
authors and Maine’s Office of Chief Medical Examiner
have tracked and reported on drug death statistics.1 In
this article, we update two previous reports from 2003
and 2010 (Sorg and Greenwald 2003; Sorg et al. 2010).
We will review overall trends in drug overdose patterns
that have continued for nearly two decades (see Figure
1), including those involving opioid pharmaceuticals,
and discuss the recent resurgence of illicit drugs heroin
and non-pharmaceutical fentanyl.
BRIEF HISTORY OF OPIOID ABUSE IN MAINE

D

uring the 1990s, synthetic and long-acting narcotic
pain medications were aggressively marketed and
more heavily prescribed, with a resulting increase in
patients who developed addictions. Originally marketed
with the erroneous belief that patients taking synthetic
opioids for pain would not become addicted, these
drugs became much more accessible, initially through
legitimate prescriptions. They subsequently became
more generally available for diversion and misuse by a
rapidly expanding number of people.
A small minority of unethical prescribers took
advantage of the opportunity to supply drugs to
opioid-addicted persons, which exacerbated the problem.
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By the early 2000s, it became apparent in Maine and
elsewhere that addiction to pharmaceutical pain medication was becoming a serious problem that had to be
addressed by society and by medical professions. An
expansion of medication-assisted treatment using methadone helped many, but also complicated the picture.
As these clinics expanded, so did opportunities for diversion. At the same time, because methadone could also
be used as an inexpensive drug for long-term pain relief,
many providers began to prescribe it for pain. Oxocodone
and methadone, both synthetic forms of opium,
emerged as prominent addictive substances. The state
began to experience the multiple consequences of the
rising tide of substance-use disorders, including an
increase in drug-induced deaths.
MAINE’S POLICY RESPONSES

P

ublic policy interventions required attention by
medical prescribers and the systems supporting
them, as well as resources for an unprecedented number
of citizens who had become addicted to opioids and who
were at increased risk of overdose. Initially the number
of treatment slots for drug addiction was expanded,
including both traditional inpatient and outpatient
treatment, as well as medication-assisted (methadone)
outpatient treatment clinics. The Drug Enforcement
Agency and the Maine Drug Enforcement Agency
began to investigate and prosecute illegal prescribing
practices. In 2004, Maine instituted one of the earliest
prescription monitoring programs (PMP) in the nation,
requiring dispensers to report “Schedule II” prescriptions, including any opioid drug, tranquilizers, and
34
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FIGURE 1: Number of Drug Deaths Occurring in Maine by Manner of Death, 1997–2015
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certain stimulants. Prescribers could now monitor the
prescriptions of their patients to forestall “doctor shopping.” In 2011, the Office of Chief Medical Examiner
was given access to the PMP to investigate decedent
prescriptions.
During the later 2000s, the opioid buprenorphine
became available as an alternative medication-assisted
treatment. Along with the help buprenorphine provided
to many patients has come increased diversion of this
drug also. This drug, however, contains naloxone, which
limits its recreational use and reduces its mortality risks.
There have been multiple professional and policy
efforts to limit or refine practices for prescribing opioid
analgesics. The Maine Medical Association and the
Maine Board of Licensure in Medicine have promoted
use of the PMP, a single medical home for patients,
patient contracts, and enhanced evaluation of pain to
document need for prescriptions. Maine has developed
similar rules for MaineCare (Medicaid), including limits
on how much opioid medication a patient may receive
and the length of time they receive such medication
without additional approvals. Doctors in the state of
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Maine who prescribe opioids are required to take an
online course on good practices for prescribing opioids
in order to renew or obtain a medical license. Finally,
prescribers as well as dispensers are now required to
participate in the PMP, and the program has become
much more efficient and timely. In addition, interstate
compacts are being developed to share prescription data
across state lines.
First responders in Maine have struggled to address
the exploding overdose rate, and law enforcement agencies have likewise struggled to address the increase in
heroin trafficking. For every fatal overdose, there are
many nonfatal overdoses that require emergency services
and medical treatment, increasing both public and
private costs. Funding for the Maine Drug Enforcement
Agency has been increased. New policy task forces have
been formed at both the community and state levels,
and funding for outpatient treatment has been increased.
Naloxone, an emergency treatment to reverse opioid
overdoses, has been made more widely available for first
responders, including law enforcement officers. As this
article is going to press, the Maine Legislature has just

35
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overturned a veto by the governor to pass a law allowing
Naloxone to be sold over the counter.
OVERDOSE DEATH INVESTIGATION IN MAINE

drugs, including analgesics, anticonvulsants, antihistamines, antidepressants, hypnotics, narcotics, sedatives,
stimulants, and tranquilizers in very small amounts.
(See sidebar for list of common drugs and their classes.)
The toxicology report includes a list of all drugs in
the victim’s system at the time of death, but their presence does not necessarily mean they were a causal or
contributing factor. For example, if a cardiac patient
also on methadone maintenance had taken over-thecounter drugs for a cold and then died of an accidental
overdose of digoxin (a cardiac drug), the toxicology
report would include methadone, digoxin, and perhaps
drugs taken for a cold such as an antihistamine. However,
only the digoxin toxicity would be listed as a cause of
death on the death certificate. In some cases, use of a
drug must be inferred from the presence of a metabolized form identified by the toxicology test. Some drugs
metabolize quickly, even after death. Breakdown of

All suspected overdose deaths are referred to Maine’s
Office of Chief Medical Examiner (OCME). The
OCME has statutory authority to investigate all suspicious, accidental, and unintended deaths to certify their
cause and manner. Prior to 2008, their investigation
usually included a scene visit whenever practicable. An
autopsy and full toxicology screen were routine in
suspected drug deaths. With the dramatic statewide
increase in these cases, the number of autopsies has been
reduced, although full toxicology is still done on all
suspected cases. The medical examiner has the legal
authority to obtain hospital or other medical records
upon request. The Maine OCME has two full-time
forensic pathologists and two full-time
death investigators headquartered in
Augusta, as well as a small number of
Common Name and Drug Class for Frequently Occurring Drugs
local medical examiner physicians who
can investigate cases not brought in for
autopsy. In the face of the large recent
Common/
Drug
Brand Name
Drug Class
increase in overdose cases, personnel
resources have not been adequate to
Amitriptyline
Elavil
Antidepressant
send an OCME representative to the
Alprazolam
Xanax
Anti-anxiety agent
scenes when someone dies outside the
Suboxone
hospital. They do send an investigator
(Buprenorphine
to do an external examination at the
Buprenorphine
Narcotic
& Naloxone),
funeral home and take a toxicology
Subutex
sample. Law enforcement personnel,
Diazepam
Valium
Anti-anxiety agent
often the primary investigators at such
scenes, use a standard protocol develDiphenhydramine
Benadryl
Antihistamine
oped jointly by the OCME and Office
Ethanol
Alcohol
Depressant
of Attorney General to collect medical
Fentanyl
Duragesic
Narcotic analgesic
evidence and information from family
or other witnesses.
Fluoxetine
Prozac
Antidepressant
Toxicology Testing

The investigation of potential
drug deaths in Maine routinely
includes full toxicology testing. Two
types of tests are done: screening to
detect the presence or absence of drugs;
and confirmatory testing to measure
the level of drugs that are present. The
comprehensive toxicology screen is
designed to detect a wide range of
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Hydrocodone

Vicodin

Narcotic analgesic

Methadone

Methadone

Narcotic analgesic

Morphine

Morphine, MS
Contin, Avinza

Narcotic analgesic

Nortriptyline

Aventyl

Antidepressant

Oxycodone

OxyContin,
Roxicodone

Narcotic analgesic

Propoxyphene

Darvon

Narcotic analgesic
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chemicals may be more extensive if there is a delay in
discovering the death.
The relationship between drug levels provided in
the toxicology report and the cause of death is not
always straightforward. Toxic drug levels sometimes
overlap with therapeutic levels. Further, there may be a
large range of individual variation in tolerance for a
given drug; doses needed in a person with high tolerance
may be lethal for a person with low tolerance. This is
especially common with opioids. Drugs may also
interact with one another in dangerous ways. It is
possible for an otherwise benign drug taken at therapeutic levels to be toxic in combination with other drugs.
The toxicology report is an essential component of
any drug death investigation, but the interpretation
requires knowledge, experience, care, and caution. For
this reason, our analysis gives more weight to the
medical examiner’s determination of cause of death than
to the raw data in the toxicology report.
Determining Manner of Death
The manner of death is clasified as natural, accidental, suicide, or homicide. A small number of deaths
classified as natural do involve drugs. These include
deaths resulting from known effects of accepted medical
treatment, such as digitalis toxicity from treatment of
congestive heart failure. It is important to note that
when death is due to a consequence of chronic (longterm) substance abuse—such as withdrawal seizures
from chronic alcoholism or cardiac inflammation (endocarditis) due to chronic intravenous drug use—the
manner is also ruled natural (Hanzlick, Hunsacker, and
Davis 2002).
Deaths may be classified as suicide in Maine only if
there is a “preponderance of evidence” that the victim
intended to cause his own death. Such evidence might
include a suicide note or history of previous attempts.
Although drug abuse in and of itself carries with it an
inherent risk of overdose and death, engaging in risky or
reckless behavior is not generally considered sufficient
evidence of suicidal intent. Medical examiners are
bound by these legal guidelines.
Maine’s strict guidelines for what can be judged
suicide means that medical examiners classify as accidents all drug deaths directly due to the unintended or
unexpected, acute (sudden or short-term) toxic effects
of a drug or poison.2 Accidental deaths thus constitute
something of a composite category; deaths under this
rubric may be the result of a range of heterogeneous
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drug uses. In a few cases, the medical examiner may not
be able to determine if a case is suicidal or accidental
and may classify the case as an undetermined manner
of death.
The Certificate of Death
For each death investigated, a medical examiner is
responsible for completion of a certificate of death,
which includes information about the death event (time,
place, how the injury or activity leading to death
occurred), the manner of death (natural, accident,
suicide, homicide, or undetermined), and the medical
cause of death (up to four levels of causation may be
specified, as well as significant conditions that contributed to the death). The death certificate information
goes electronically from the OCME to the Maine
Department of Health, Office of Data, Research and
Vital Statistics. State-level mortality information is then
forwarded to the Centers for Disease Control and
Prevention’s National Center for Health Statistics, where
the cause of death is coded. Both the state and the
federal government use the standardized codes from
death certificate data to generate statistics about population mortality.
DEFINING “DRUG DEATHS”

I

n our studies, drug deaths, sometimes labeled “overdose deaths” or “poisoning deaths,” include all medical
examiner cases in which a drug was determined to be
either a cause (primary cause or one of the three underlying causes) of death or a significant contributing factor.
The deaths reported in this article are for the period
from 2009 through 2015. These are occurrent deaths,
that is, deaths that occurred within the state of Maine.
Deaths of Maine residents who may have died in other
states are not included here.
Deaths caused directly or indirectly by drugs may
involve illicit substances (such as heroin or cocaine) or
pharmaceutical drugs. Deaths caused by chronic
alcohol abuse, in which no other drugs were implicated,
were excluded; however, deaths in which both alcohol
and drugs were causal or contributing factors have
been included.
Drug deaths do not include deaths due to trauma,
such as with a motor vehicle fatality, even if the decedent had drugs in her system and may have been
impaired. Although there is a legal impairment standard
for alcohol impairment and a legal requirement for the
37
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has remained within
the range of 25 to 38
each year; that type
300
of variation is likely
272
Total
Pharm Opioid
Illicit
random change due
250
to the small number.
During the same
208
period, the number of
200
accidental deaths rose
179
176
167
164
sharply from 64 to
163
155
124
between 2001 and
150
2002,
with another
124
122
113
111
sharp
increase
from
108
105
101
2012
to
2015,
going
100
76
from 115 to 272.
Since our last
47
39
50
report in 2010 (Sorg
18
17
17
et al. 2010), Maine
has seen the number
0
of
deaths due to phar2009
2010
2011
2012
2013
2014
2015
maceutical
opioids
*Illicit drugs include heroin, non-pharmaceutical fentanyl, and cocaine. Drug categories are
stabilize, with a
combined in some deaths.
dramatic increase in
illicit drug trafficking
and abuse. As shown
OCME to measure alcohol levels in the blood for motor
in Figure 2, in 2009 there were 18 deaths due to heroin,
vehicle fatalities, there is no legal standard for impairnon-pharmaceutical fentanyl, and cocaine, a number
ment from drugs.
that remained about level through 2011. But, beginEven when drugs are not the primary cause of
ning in 2012, the number of deaths due to these illicit
death, they may be an important component of the
drugs began to increase sharply, doubling by 2012,
overall causal sequence. For example, a medical examdoubling again by 2014, and again by 2015, an increase
iner may determine that lack of oxygen to the brain
overall of 890 percent. In 2015, the number of illicit
(brain anoxia) was the immediate cause of death, but
drug deaths surpassed the number caused by pharmathat brain anoxia was due to heroin toxicity. In that case,
ceutical opioids (Figure 2).
heroin toxicity would be listed as an underlying
In the last few years the rate of drug-induced
(secondary) cause on the certificate of death.
deaths, particularly those attributable to pharmaceutical and illicit opioids, has risen drastically across the
MORTALITY RATES
United States. According to a recent analysis by the
Centers for Disease Control and Prevention, Maine was
he total annual number of drug-induced deaths
one of 14 states nationwide that saw a statistically
occurring in Maine increased dramatically from 34
significant percentage increase in drug-induced deaths
in 1997 to 272 in 2015, with large increases in 2002
from 2013 to 2014, with a 27.3 percent climb (Rudd
and further increases during the last four years, 2012–
et al., 2016). Among other New England states, both
2015. As we show, the recent increase is due predomiNew Hampshire and Massachusetts also experienced
nantly to accidental rather than suicidal overdoses and
statistically significant increases in drug-induced deaths
is largely the result of heroin and non-pharmaceutical
during this same time period, with Massachusetts
fentanyl. Figure 1 shows the total number of suicidal
witnessing an increase of 18.8 percent, and New
and accidental deaths by year. Beginning in 2001, the
Hampshire, an increase of 73.5 percent. Among those
number of drug-induced suicides has fluctuated, but
14 states with statistically significant percentage
Number of Deaths Due to Pharmaceutical Opioids or Illicit
Drugs, 2009–2015*

Number of Deaths

Figure 2:

T
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Table 1:
Total Number and Percentage of Drug Deaths by
increases, Maine, New Hampshire, and
County, 2009–2015*
Massachusetts ranked third, second, and
seventh, respectively.
Maine’s drug deaths are spread
Percentage Percentage
Number
of Total
of 2010
Percentage
throughout the state and thus are not a
of Drug
Drug
Maine
Deviation
strictly urban phenomenon. In Table 1, we
Deaths
Deaths
Census
from
summarize the total number and
County
2009–2015
2009–2015
Population
Census
percentage of drug deaths by county,
Androscoggin
129
9.8
8.1
1.7
compared to each county’s proportion of
Aroostook
47
3.6
5.4
-1.8
the 2010 Maine population. Although the
Cumberland
338
25.6
21.2
4.4
proportion of drug deaths is similar to the
Franklin
22
1.7
2.3
-0.6
population in most counties, Cumberland
County has 4.4 percent more deaths than
Hancock
44
3.3
4.1
-0.8
would be predicted based on its population,
Kennebec
141
10.7
9.2
1.5
and Oxford County has 2.0 percent less.
Knox
33
2.5
3.0
-0.5
We calculated the rate per 100,000 for
Lincoln
31
2.3
2.6
-0.3
deaths occurring in each county (see Table
2). Mortality rates in larger counties are
Oxford
31
2.3
4.3
-2.0
similar to each other and also more stable
Penobscot
150
11.4
11.6
-0.2
over time, largely because they have larger
Piscataquis
20
1.5
1.3
0.2
populations (e.g., for 2013–2015,
Sagadahoc
15
1.1
2.7
-1.6
Androscoggin is 21.0; Cumberland is 20.8,
and Kennebec is 21.6). In Table 2, we have
Somerset
50
3.8
3.9
-0.1
used three-year rolling averages to smooth
Waldo
36
2.7
2.9
-0.2
out some of the year-to-year random flucWashington
38
2.9
2.5
0.4
tuations that occur in counties with small
York
195
14.8
14.8
0.0
populations, but this small-number
problem persists. Thus, some rate changes
Total
1,320
100
100
—
over time in the smaller counties are likely
*Compared to county population (U.S. 2010 Census).
due to random fluctuations rather than
changes in drug use. Nevertheless, several
non-urban counties have experienced the
lowest drug mortality rates per 100,000 population (e.g.,
being (like most Mainers) overwhelmingly Caucasian,
for 2013–2015, Aroostook is 10.2, Franklin is 9.8,
the population of those who die of drug-related causes
Oxford is 8.1, and Sagadahoc is 7.6). Most counties in
is surprisingly diverse.
Maine, however, have seen an increase over time in the
Both men and women are included among overrate of drug deaths. The map (Figure 3) shows the
doses, but their distribution does not mirror the general
average ratio of drug deaths per 100,000 population in
population. Table 3 compares the age and sex structure
Maine’s counties in the 2009 to 2015 period.
of Maine drug deaths from 2009 to 2015 to that of the
U.S. 2010 census for Maine. The drug death population
DECEDENT CHARACTERISTICS
is clustered in the age categories from 25 to 54. Males
disproportionately occupy younger, and females older,
ome victims of drug-induced overdose in Maine
age categories, whereas the Maine general population is
are people most Mainers would characterize as
more evenly distributed among age and sex categories.
marginal: without a stable place to live or a stable
Men outnumber women approximately two to one
work history, perhaps with histories of mental illness or
among accidents (703 men vs 341 women), and women
serious substance abuse problems. Others, however, are
outnumber men by about 50 percent among suicides
well-educated homeowners, employed at responsible
(130 women vs 90 men). During the 2009–2015 period,
jobs in a variety of skilled occupations. Aside from
there were 1,320 deaths; decedent ages range from 17 to
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Maine; suicidal overdose victims are
even less likely (43 percent) to have
been born in the state. Racial make-up
is similar across categories.
2009–
2010–
2011–
2012–
2013–
County
2011
2012
2013
2014
2015
As is true for many middle-aged
Mainers, these drug death victims had
Androscoggin
13.6
13.6
13.3
18.0
21.0
chronic medical problems, including
Aroostook
9.3
9.3
11.6
9.7
10.2
heart, lung, and liver diseases, as well as
Cumberland
13.4
13.8
14.7
16.4
20.8
obesity. Conditions such as these can
Franklin
11.9
11.9
9.8
7.6
9.8
play a role in drug-related deaths by
Hancock
12.9
8.0
6.1
8.6
11.6
reducing physical capacity. For instance,
liver diseases such as hepatitis or
Kennebec
13.6
14.5
15.3
15.8
21.6
cirrhosis
can reduce the ability of the
Knox
10.1
10.9
10.9
12.6
15.1
liver to detoxify blood. This reduced
Lincoln
9.7
9.7
12.6
13.5
16.4
ability helps keep blood drug levels
Oxford
8.1
5.2
6.3
5.8
8.1
dangerously high. Chronic obstructive
pulmonary disease (COPD) reduces
Penobscot
14.1
12.6
13.0
12.8
14.5
lung
capacity, which can enhance the
Piscataquis
24.7
20.9
5.7
5.7
13.3
respiratory depression produced by
Sagadahoc
3.8
5.7
6.6
8.5
7.6
high levels of opiates. Obesity can
Somerset
12.1
12.8
13.4
14.7
14.0
obstruct the airway, particularly in
some body positions, thus potentially
Waldo
13.8
14.6
15.5
13.8
12.0
increasing
the risk from respiratory
Washington
14.2
18.3
19.3
19.3
18.3
depression caused by opiates.
York
12.7
11.0
10.5
13.9
16.6
Cardiovascular disease further increases
Statewide
12.6
12.2
12.4
13.7
16.5
risks from respiratory depression by
reducing the capacity of the heart and
*This occurrent ratio excludes deaths of Maine residents that occurred in other states.
lungs to process oxygen. Witnesses to
the circumstances of overdose deaths
92, with the exception of two children age 2 and one age
often describe the victim as “sleeping” and “snoring”
7. The average age of all decedents for the period from
heavily just before death, an unrecognized sign of respi2009 to 2015 is 43. More than half (53 percent) of these
ratory distress.
decedents were aged 35 to 55. Accident victims are on
Decedents may have been taking medications
average slightly younger (average age 41with sexes
prescribed legitimately for conditions such as pain,
combined, males 40, females 43) than those who
depression, or anxiety. These medications sometimes
commit suicide (average age 51 with sexes combined,
have dangerous side effects if taken incorrectly or
males 49, females 52), and twice as likely to be male.
combined with other drugs. They may interact dangerCompared to averages for Maine’s population as a
ously with other drugs of abuse. Alcohol, as well as some
whole, overdose victims are less educated and less likely
medications prescribed for anxiety or depression, if
to have been born in Maine. Table 4 compares the 2015
taken in conjunction with opioids, can boost the blood
drug deaths by manner of death to the Maine 2010
levels—hence the toxic effects (Davis et al. 2012; Sorg et
census population. The 2015 accidental death victims
al. n.d.).
are about twice as likely (16 percent) as the general
population (9 percent) to have less than a high school
KEY DRUGS INVOLVED
education and approximately one-third as likely (8
percent) as the general population (28 percent) to have
f the pharmaceutical drugs specifically listed
a bachelor’s degree or higher. Accidental overdose
on death certificates as either cause or contribvictims are less likely (57 percent) than members of the
uting factor, three classes predominate: opioid analgeneral population (66 percent) to have been born in
gesics (including for example methadone, oxycodone
Table 2:

Rate of Drug Deaths per 100,000 Population by
County, Three-year Rolling Averages, 2009–2015*

O
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Figure 3:

Average Rate of Drug Deaths per 100,000
Population by County, 2009–2015*

Aroostook
9.3

Piscataquis
16.3
Somerset
13.7

Penobscot
13.9
Washington
16.5

Franklin
10.2
Hancock
11.6
Oxford
7.7

Kennebec
16.5

Waldo
13.3

Androscoggin Lincoln Knox
11.9
17.1
12.9
Sagadahoc
6.1
Cumberland
17.1

Table 3:

York
14.1

6 – 9.9
10 – 12.9

is a non-pharmaceutical opioid, has emerged as one of
the most frequent causes, along with non-pharmaceutical fentanyl (and acetyl-fentanyl). Heroin, cocaine,
and non-pharmaceutical fentanyl are the most prominent of the illicit drugs in Maine deaths.
Of all overdoses between 2009 and 2015, 67
percent had at least one pharmaceutical drug mentioned
as a cause of death (82 percent for accidents and 98
percent for suicides). This is much greater than the 63
percent for accidents and about the same as the 94
percent for suicides noted in our 2003 article (Sorg and
Greenwald 2003). However, it is important to note a
change in how medical examiners certify deaths with
multiple drugs; they are much more likely to mention
all potential co-intoxicants on the death certificate.
An overwhelming majority of pharmaceutical
opioids and benzodiazepines implicated as causing or
contributing to overdose deaths since 2009 lack any
evidence of a prescription. For example, of the 96 cases
in 2015 in which a pharmaceutical opioid was implicated as a cause of death (35 percent of cases overall),
only 7 percent had a prescription.
Most drug-induced fatalities involve more than one
drug. In our 2003 article, for about a quarter of the
deaths that occurred in the 1997–2002 period, the toxicology was so complex that the cause of death was listed
simply as “polydrug” or “mixed drug.” Practice guidelines for medical examiners have changed since then,
however (see Davis et al. 2012), and it is now more
Age and Sex Distribution for Drug Deaths from
2009 to 2015 Compared with Maine 2010 Census
Population

13 – 14.9
15 – 16.9
17 and above

Age
Categories

State Rate – 14.2

*This occurrent ratio excludes deaths of Maine
residents that occurred in other states.

and hydrocodone), antidepressants (most
frequently SSRIs [selective serotonin reuptake
inhibitors] such as fluoxetine or tricyclic
antidepressants such as amitriptyline), and
benzodiazepines (especially anti-anxiety
agents such as diazepam and alprazolam).
Alcohol (a depressant) and cocaine (a stimulant) are also frequently listed. Heroin, which
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2010 Maine Population
Male

Female

Both
Sexes

2009–2015 Deaths
Male

%
<18

22

20

Female

Both
Sexes

%
21

0

1

1

18-24

9

8

9

7

6

6

25-34

11

11

11

27

15

22

35-44

13

13

13

24

24

24

45-54

16

16

16

27

33

29

55-64

14

14

14

12

16

13

65+

14

17

16

3

6

4

Total

100

100

100

100

100

100
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common to list any potentially interacting or synergistic substances on
the death certificate.

Table 4:

Oxycodone and Methadone

Demographic Characteristics of Decedents in
2015 by Manner of Death, Compared with Maine
2010 Census Population
Maine 2010

Number of Deaths

2015 Deaths,
All Deaths
Accidents
Suicides
Population
Oxycodone is a synthetic opioid
Category
%
often prescribed for pain. Since 1995,
it has been marketed in the longRace
lasting form OxyContin, but is also
Caucasian
95
97
100
95
prescribed in lower dose, shortEducation
(ages
25+)
er-acting products. Once metaboLess than high school
14
16
4
9
lized, however, OxyContin and other
commercial forms of oxycodone are
High School
85
84
96
91
indistinguishable. Oxycodone has
Bachelors or Higher
9
8
19
28
been one of the key intoxicants found
Nativity
in Maine decedent toxicology since
Born in Maine
56
57
43
66
the late 1990s and is often the most
commonly identified opioid across all
overdose decedents in Maine.
Figure 4:
Number of Deaths Caused by Methadone, Oxycodone,
Methadone is a synthetic opioid
and/or Heroin, Alone or in Combination with Other
with two distinct primary uses.
Drugs, 2009–2015
Because it is long-acting, without the
same euphoric high as heroin, it has
300
272
long been used in the treatment of
Total
Methadone
Oxycodone
Heroin
opioid addiction, prescribed in liquid,
250
powder, or wafer form. Methadone is
also frequently used in pill form for
208
chronic pain. Toxicology screenings
200
cannot discriminate between these
179
176
167
163
various forms. Methadone pharma155
cology is particularly complex.
150
Tolerances vary widely from one
individual to another. The range of
107
100
blood levels seen with therapeutic
doses may overlap with the toxic
57
range. As with other opioids, people
50
48
41
50
42
28
37
38
can die of fairly low, theoretically safe,
20
48
50
37
doses, often when alcohol or other
34
13
34
30
7
7
32
16
drugs are present or if the individual
0
2009
2010
2011
2012
2013
2014
2015
has low tolerance. An individual’s
tolerance can also change with
circumstance. Tolerance is reduced
for regular users who, for one reason or another, stop
common adverse effect of all opioids and the one most
receiving regular doses, e.g., those who are in jail. When
likely to prove fatal.
they resume taking dosages to which they had been
Figure 4 illustrates the trends in the frequencies of
accustomed, they are at greater risk for fatal overdose.
deaths due to key opioids methadone and oxycodone,
The slow onset of methadone’s effects may prompt some
contrasted with heroin trends. The rates of oxycodone
users to take more methadone, with fatal effect. This can
and methadone have been similar during the 2009–
increase the risk of respiratory depression, the most
2015 study period, temporarily dropping during 2012,
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but stablizing since 2013. These drugs are sometimes
found together.
Heroin and Non-pharmaceutical Fentanyl

analogues were unevenly distributed around the state.
The southernmost counties of Cumberland and York
have had a disproportionate share of the heroin/
fentanyl deaths. Cumberland County has 21percent of
Maine’s 2010 population, but has had 34 percent of the
heroin/fentanyl deaths, 13 percent more than expected.
York, with 15 percent of the population, had 19 percent
of the heroin/fentanyl deaths. Many other counties
have had fewer than expected heroin/fentanyl deaths
through 2015, based on their poulations; for example,
Penobscot, with 12 percent of Maine’s population, had
9 percent of the heroin/fentanyl deaths, 3 percent less
than would be expected. The map (Figure 6) displays
the average rate of deaths per 100,000 due to heroin
and non-pharmaceutical fentanyl by county over the
2009–2015 period. The four most southern, contiguous
counties along the Interstate-95 corridor, along with
Washington County, have experienced the highest rates
overall during this period.
Those who died due to pharmaceutical opioids are
much older on average (males 43; females 46) than
those who died due to heroin and/or non-pharmaceutical fentanyl (males 38; females 36). But the distribution is skewed, as shown in Figure 7. For heroin and
non-pharmaceutical fentanyl deaths, males far outnumber females, and they cluster largely in the 25- to

Number of Deaths

Heroin is an illicit opioid associated with intravenous drug use. Heroin is sometimes difficult to identify
in toxicology. Because it metabolizes quickly in the body
to morphine, the toxicology reports morphine, not
heroin. Morphine could be pharmaceutical morphine
sulfate, an opioid analgesic, or metabolized heroin. If
they lack clear evidence of heroin from the scene investigation, medical examiners are likely to name the drug
causing death as “morphine” on the death certificate,
even though many of these cases are in fact due to
heroin. To avoid undercounting heroin, our method has
been to cast a wider net. We examine the scene investigation data to rule out that the death is due to morphine
sulfate pills and rule out that the decedent has a prescription for pharmaceutical morphine; we then count any
remaining cases of morphine toxicity as heroin.
Fentanyl is likewise a substance found in toxicology that may be pharmaceutical or, since 2011,
non-pharmaceutical. This substance is being manufactured in Asia and has been widely distributed as both
powder and pills by drug traffickers in the United States.
Maine began seeing non-pharmaceutical fentanyl
deaths in 2012. Similar to our
approach with heroin, we rule out the
Figure 5:
Number of Maine Drug Deaths in Which Heroin or
presence of known pharmaceutical
Fentanyl (and Its Analogues) Were Listed as the
fentanyl products such as fentanyl
Cause of Death, Alone or in Combination, 2009–2015
patches or known prescriptions for the
180
decedent; we then count any remaining
cases of fentanyl toxicity as non-pharHeroin Only
160
maceutical fentanyl.
Fentanyl Only
Deaths caused by heroin had
140
Heroin and Fentanyl
37
declined during the mid-2000s. They
began to rise in 2011, along with
120
non-pharmaceutical fentanyl. Fentanyl
and its analogue acetyl-fentanyl are
100
49
sometimes found alone, sometimes in
80
combination with each other, and
11
often combined with heroin in dece27
60
dent toxicology (see Figure 5). Illicit
drug dealers often combine these drugs
1
40
and sell the product as heroin. Fentanyl
70
1
is many times more potent than heroin
46
20
33
5
and often fatal.
28
10
3
13
Drug deaths caused by heroin or
7
7
0
non-pharmaceutical fentanyl and its
2009
2010
2011
2012
2013
2014
2015
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Figure 6:

34-age category (100 male decedents). The age distribution for females is similar to the pattern for pharmaceutical opiods.

Average Drug Deaths Due to Heroin and
Non-pharmaceutical Fentanyl per 100,000
Population by County, 2009–2015*

CONCLUSION

S

ubstance abuse is a critical problem that continues
to plague Maine state and local governments and
the communities they serve. Death is only the most
dramatic consequence of a behavior pattern associated
with crime, increased accidents, lost time at work,
serious health problems, and untold anguish for family
and loved ones.
A 2010 analysis of the impact of substance abuse on
the state of Maine revealed that the total economic
burdern resulting from drug and or alcohol abuse was
over $1.4 billion in 2010 dollars, or $1,057 for every
Maine resident (Rogers, Sorg, and Wren 2013). The 175
drug-induced deaths in 2010 represent a $168.7 million
in loss in potential lifetime earnings for those decedents.
Among individuals in the labor force who had a drug
problem in 2010, there was an approximatey $36.1
million loss of productivity. Concerned members of the
public often focus on the most exotic elements—illegal
drugs such as heroin or cocaine or legal drugs such as
methadone that seem to be used primarily by a definable
population. Yet the problem is much more complex.

Aroostook
0.6

Piscataquis
3.3
Somerset
1.4

Penobscot
2.9
Washington
4.8

Franklin
2.8
Hancock
2.1
Oxford
1.7

Kennebec
4.1

Waldo
2.2

Androscoggin Lincoln Knox
2.2
4.4
2.1
Sagadahoc
0.8
Cumberland
6.1

Figure 7:

Age-Sex Distribution for Deaths Caused by Heroin
and Non-pharmaceutical Fentanyl, 2009–2015
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York
4.8

under 1.0

Male

120
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Female
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2.1 – 3
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100

Above 5

Number of Deaths

State Rate – 3.7

*This occurrent ratio excludes
deaths of Maine residents that
occurred in other states.
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Study of Maine’s medical examiner files indicates
that to reduce the risk of drug-related fatalities, policy
initiatives must address this complexity of drug use.
Here we make a few points on substance abuse issues
coming from our study:
• At least one pharmaceutical drug is named as
a cause of death (alone or in combination with
other drugs) in the overwhelming majority (85
percent) of drug deaths in Maine, 2009–2015.
Most of these drugs have been diverted. A
minority are prescribed, but misused.
• Within the past three years, illicit drugs including
heroin, non-pharmaceutical fentanyl formulations, and cocaine are involved in over half
(51 percent) of Maine drug deaths, frequently
combined with pharmaceuticals or alcohol. This
emergent pattern is worsening: the proportion
of illicit drugs identified in drug death cases has
increased from 27 percent in 2013 to 60 percent
in 2015.
• Alcohol has been a prominent part of the
substances listed on death certificates as either
cause of death or contributing factor, named
in 20 percent of cases in the 2009–2015
period. Maine’s substance abuse problem is still
frequently an alcohol abuse problem.
• Better public education on signs of respiratory
distress might save lives. Unwitting witnesses
to drug deaths frequently mistake respiratory
distress for snoring and fail to summon medical
assistance.
Our study of the forensic epidemiology of drug
mortality continues. We hope our findings will provide
a more nuanced understanding of the circumstances
and risks of drug abuse and drug abusers and will
prompt improved public policy initiatives that effectively address the full range of Maine’s problems with
drug use and abuse. ACKNOWLEDGMENTS
The authors would like to acknowledge, with thanks, all
those who assisted with various portions of our data collection and analysis, especially the staff of the Maine Office of
Chief Medical Examiner and especially research assistant
Thomas Mitchell.
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ENDNOTES
1

The first report, funded by the U.S. Department of
Justice Byrne Fund, covered the period 1997 to the end
of June 2002. Funding from the U.S. Department of
Justice allowed us to continue tracking through 2005.
A second comprehensive report in 2010 was funded
by the Offices of United States Attorneys. More recent
tracking and funding for the current study have been
supported by the Maine Office of Attorney General.

2

This designation is consistent with guidelines recently
published by the National Association of Medical
Examiners (Hanzlick, Hunsacker, and Davis 2002) for
determining the manner of death when drugs are
involved. Jurisdictions outside Maine may use different
criteria.
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